Disease Information for Anti-Fibrinolysis Medication Administration/Toxicity

Ads
Laboratory Tests
Abnormal Lab Findings - Decreased
Fibrinogen, plasma (Lab)
Abnormal Lab Findings - Increased
Amino acids serum (Lab)
Trypsin inhibitor (Lab)
Associated Diseases & Rule outs
Associated Disease & Complications
Cerebral vein thrombosis/phlebitis
Rhabdomyolysis
Thromboembolic disease
Hypercoaguability
Disease Mechanism & Classification
Drugs
DRUG/Anti-plasmin effect
DRUG/Fibrinolysis inhibitor medication (example)
DRUG/Hemostatic drug/effect (example)
Pathophysiology
Pathophysiology/Fibrinolytic suppression
Pathophysiology/Hemostasis activation/effect
Process
PROCESS/Medication/Drug (CONFIRM dose/before treatment)
Treatment
Drug Dosage
DRUG/Generic available
Definition

Ant-fibrinolysin medication indicated in some pancreatitis cases, coagulopathy [not DIC except with pro-myelocytic leukemis]; There are two drugs in this class: Amino-epsilone caproic acid [amicar] and tranexamic acid [cyclokapron]. DVT and clotting can occur.

(Edit)

External Links Related to Anti-Fibrinolysis Medication Administration/Toxicity
Google
Wikipedia
Merck
Images
PubMed (National Library of Medicine)
NGC (National Guideline Clearinghouse)
Medscape (eMedicine)
Harrison's Online (accessmedicine)
NEJM (The New England Journal of Medicine)
Ads